PSquared Asset Management AG Quant / Systematic

Location: Zurich, Switzerland

CIK: 0001623624 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 13, 2020

Total Value: $550M (100.0% shares, 0.0% debt)

Holdings (7)

— CYPRESS SEMICONDUCTOR CORP 34.0%

Value $187M Shares 8,013,563 Est. Cost $22.62 Unrealized —

— ALLERGAN PLC 31.6%

Value $174M Shares 907,744 Est. Cost $171.32 Unrealized —

— ZAYO GROUP HLDGS INC 14.0%

Value $77.03M Shares 2,223,072 Est. Cost $33.49 Unrealized —

— TIFFANY & CO NEW 12.5%

Value $68.65M Shares 513,644 Est. Cost $133.65 Unrealized —

— MEDICINES CO 3.1%

Value $16.99M Shares 200,000 Est. Cost $84.94 Unrealized —

— WABCO HLDGS INC 3.0%

Value $16.55M Shares 122,177 Est. Cost $133.75 Unrealized —

— QIAGEN NV 1.9%

Value $10.25M Shares 303,250 Est. Cost $33.80 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	CYPRESS SEMICONDUCTOR CORP	8,013,563	$187M	34.0%	$22.62	—	COM	232806109
—	ALLERGAN PLC	907,744	$174M	31.6%	$171.32	—	SHS	G0177J108
—	ZAYO GROUP HLDGS INC	2,223,072	$77.03M	14.0%	$33.49	—	COM	98919V105
—	TIFFANY & CO NEW	513,644	$68.65M	12.5%	$133.65	—	COM	886547108
—	MEDICINES CO	200,000	$16.99M	3.1%	$84.94	—	COM	584688105
—	WABCO HLDGS INC	122,177	$16.55M	3.0%	$133.75	—	COM	92927K102
—	QIAGEN NV	303,250	$10.25M	1.9%	$33.80	—	SHS NEW	N72482123